Elena Sebastian

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The Mars Environmental Dynamics Analyzer, MEDA. A Suite of Environmental Sensors for the Mars 2020 Mission.

The Mars Environmental Dynamics Analyzer, MEDA. A Suite of Environmental Sensors for the Mars 2020 Mission.

Journal: Space science reviews

Published: March 08, 2021

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

Journal: Annals of hematology

Published: August 13, 2015

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

Journal: Leukemia

Published: January 09, 2015

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction.

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction.

Journal: Applied immunohistochemistry & molecular morphology : AIMM

Published: July 04, 2014

Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?

Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?

Journal: Annals of hematology

Published: June 01, 2014

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

Journal: Leukemia

Published: August 13, 2013

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

Journal: Blood

Published: July 12, 2013

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.

Journal: British journal of haematology

Published: May 15, 2013

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

Journal: Leukemia

Published: May 07, 2013

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

Journal: Leukemia

Published: December 29, 2012

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

Journal: European journal of haematology

Published: July 13, 2012

The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

Journal: Annals of hematology

Published: May 17, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026